Glenzocimab
Product Specifications
CAS Number
2101829-58-5
Target
Others
Related Pathways
Others
Purity
1
Bioactivity
Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
JH918759 1 Each
(S, E) -4- (Methylsulfonyl) -1-phenylbut-3-en-2-amine hydrochloride
Sign In for Pricing
View Details 
PKSH033973-01 20 µg
Recombinant Human Interleukin-2/IL-2 (C-6His-Avi) Biotinylated
Sign In for Pricing
View Details PKSH033973-02 100 µg
Recombinant Human Interleukin-2/IL-2 (C-6His-Avi) Biotinylated
Sign In for Pricing
View Details 